Clinical Trials Directory

Trials / Conditions / Fulminant Hepatic Failure

Fulminant Hepatic Failure

9 registered clinical trials studyying Fulminant Hepatic Failure — 1 currently recruiting.

StatusTrialSponsorPhase
CompletedMaternal And Fetal Outcomes in Pregnant Women With Liver Disease
NCT06594237
Muhammad Aamir Latif—
RecruitingTReatment for ImmUne Mediated PathopHysiology
NCT04862221
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2
CompletedSteroids in Fulminant Hepatitis A in the Pediatric Age Group
NCT02375867
National Liver Institute, EgyptPhase 4
TerminatedSafety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
NCT01875874
Vital Therapies, Inc.Phase 2
WithdrawnSafety and Efficacy of the Extracorporeal Liver Assist Device (ELAD®) In Patients With Fulminant Hepatic Failu
NCT00832728
Vital Therapies, Inc.Phase 2
TerminatedStudy of N-Acetylcysteine in Acute Liver Failure (ALF)
NCT00896025
University of Texas Southwestern Medical CenterPhase 4
CompletedPhase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure
NCT00030225
Vital Therapies, Inc.Phase 2
CompletedCerebral Microdialysis in Patients With Fulminant Hepatic Failure
NCT00836420
Rigshospitalet, Denmark—
CompletedA Multi-Center Trial to Study Acute Liver Failure in Adults
NCT00518440
William Lee—